Drug intelligence / Profile preview

diclofenac + glucosamine + chondroitin

Development stage
Unknown
Lead developer
Carnot Laboratorios
Modality
Small Molecules
Administration
Topical
01

Overview

Dolaren Crema is a topical anti-inflammatory and analgesic combination therapy developed by Carnot Laboratorios. It is a fixed-dose combination product containing the nonsteroidal anti-inflammatory drug (NSAID) **diclofenac**, along with **glucosamine** and **chondroitin sulfate**. Diclofenac provides rapid pain relief and reduces inflammation by inhibiting the cyclooxygenase enzymes (COX-1 and COX-2), thereby blocking the synthesis of pro-inflammatory prostaglandins. Glucosamine and chondroitin are structural components of the cartilage matrix and are included to support joint health and provide symptomatic relief in degenerative joint conditions. The cream is primarily indicated for the localized treatment of pain and inflammation associated with osteoarthritis and other musculoskeletal disorders. It is approved and marketed in various Latin American regions, including Mexico.

Brand names
Dolaren Crema
Other names
Dolaren
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on diclofenac + glucosamine + chondroitin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diclofenac + glucosamine + chondroitin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call